(3AS,5R,8AS,9R,9AS)-5-BENZYL-9-HYDROXYDECAHYDROFURO-[3,2-F]-INDOLIZIN-5-IUM-BROMIDE
Compound with spectra: 1 NMR
![(3AS,5R,8AS,9R,9AS)-5-BENZYL-9-HYDROXYDECAHYDROFURO-[3,2-F]-INDOLIZIN-5-IUM-BROMIDE](/api/compound/8c6gmYMkmKt.png?ph=true&h=300&w=458 "(3AS,5R,8AS,9R,9AS)-5-BENZYL-9-HYDROXYDECAHYDROFURO-[3,2-F]-INDOLIZIN-5-IUM-BROMIDE")
| SpectraBase Compound ID | 8c6gmYMkmKt |
|---|---|
| InChI | InChI=1S/C17H24NO2.BrH/c19-16-15-7-4-9-18(15,11-13-5-2-1-3-6-13)12-14-8-10-20-17(14)16;/h1-3,5-6,14-17,19H,4,7-12H2;1H/q+1;/p-1/t14-,15-,16+,17-,18?;/m0./s1 |
| InChIKey | JIHCIXLMSBZMHV-VNZMZREASA-M |
| Mol Weight | 354.29 g/mol |
| Molecular Formula | C17H24BrNO2 |
| Exact Mass | 353.099042 g/mol |
| Parent InChIKey | YVRYYXNAVGTSOD-KYLYMASSSA-M |
| Enantiomer InChIKey | JIHCIXLMSBZMHV-KQVIMOEWSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
5-exo,6-exo-Isopropylidenedioxy-2-methyl-2-azabicyclo[3.2.1]octan-3-one
(1R)-N-BENZYL-3,6-DI-O-BENZYL-1-C-BUTYL-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL
1,2,3,4-tetrahydro-1,4-ethano-6H-benzo[b]quinolizin-6-one
N-{(S)-1-Hydroxy-3-(4-methoxybenzyloxy)-2-[(2T,3R,4S)-3-benzyloxy-5-methoxyoxolan-2-yl]propan-2-yl)trichloroacetamide
9-Benzyl-5-oxa-9-azatricyclo[5.2.1.0(4,8)]decan-2-one
8-BENZYL-5-OXA-9-AZATRICYCLO-[5.2.1.0(4,8)]-DECAN-2-ONE
4H-Quinolizin-4-one, 8-(formyloxy)octahydro-6-(3-iodo-4-methoxyphenyl)-, (6.alpha.,8.beta.,9a.alpha.)-(.+-.)-
(1S,2R,7R,8S,8aR)-(-)-1,2-O-Isopropylidene-7,8-dihydroxyindolizidine
(1S,2R,8R,8aR)-8-(Benzyloxy)-1,2-(isopropylidenedioxy)indolizine
(2R,1'R,5'R)-(-)-2-(2-AZABICYCLO-[3.3.0]-OCTAN-2'-YL)-1,1,2-TRIPHENYLETHANOL
| Title | Journal or Book | Year |
|---|---|---|
| Combined Chemical, Biological and Theoretical DFT-QTAIM Study of Potent Glycosidase Inhibitors Based on Quaternary Indolizinium Salts | European Journal of Organic Chemistry | 2012 |